You are here

AusPAR: Nivolumab and ipilimumab

Australian Public Assessment Report

11 May 2021
AusPAR Details
AusPAR
Active Ingredient
Nivolumab and ipilimumab
Product Name
Opdivo and Yervoy/Winglore
Sponsor
Bristol-Myers Squibb Australia Pty Ltd
Submission Number
PM-2018-02005-1-4 and PM-2018-02012-1-4
Submission Type
Extension of indication
Decision
Withdrawn
Publication Date

11 May 2021